Sansure Biotech Inc. (688289.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.02B |
| Enterprise Value | 8.12B |
| P/E Ratio | 57.96 |
| PEG Ratio | -1.23 |
| Price/Sales Ratio | 5.45 |
| Price/Book Ratio | 1.31 |
| Enterprise/Revenue | 3.84 |
| Enterprise/EBITDA | 25.58 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.1 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 1.64B |
| Revenue/Share | 2.58 |
| Gross Profit | 1.24B |
| EBITDA | 339.84M |
| Net Income | 198.94M |
| Diluted EPS | 0.34 |
Balance Sheet
| Total Cash | 3.92B |
| Total Cash/Share | 6.31 |
| Total Debt | 1.2B |
| Total Debt/Equity | 0.17 |
| Current Ratio | 4.26 |
| Book Value Per Share | 11.63 |
Price History
| 52-Week Change | -27.3 |
| 52-Week High | 23.45 |
| 52-Week Low | 13.4 |
| Moving Average 50 Days | 15.9 |
| Moving Average 200 Days | 18.72 |
Statistics
| Average Volume | 5.09M |
| Shares Outstanding | 579.39M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.52 |
| Trailing Annual Dividend Yield | 3.47 |
| Payout Ratio | 2.13 |
| Last Split Factor | 37:25 |
| Last Split Date | June 01, 2022 |
AD
